MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Researchers tested the drug on 40 adults with long-term type 1 diabetes in the Insulin Resistance in Type 1 Diabetes Managed ...

Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands.

Researchers at the University of Sussex, in collaboration with scientists from different institutes worldwide, have ...

Abbott (NYSE: ABT) will present new data at the American Association for Cancer Research (AACR) Annual Meeting 2026 demonstrating continued advancements in its multi-biomarker, multi-cancer early ...

The exhaustion that still clings after a full night of sleep and constant infections could be connected to a problem millions ...

Scientists have discovered that the MLKL protein, known as a mediator of cell death, covertly accelerates the aging of ...

For long-term type 2 diabetes management, focus is shifting from blood sugar numbers to the scale. Learn why losing 15% of body weight may be the key to resetting your pancreas and achieving remission ...

Wearable technologies are starting to reshape how people manage health. Continuous glucose monitors that measure blood sugar ...

For the first time, a simple blood draw has the potential to identify dozens of cancers at an early stage, when treatment is more effective and less costly.

One of the latest clock-reversing experiments causing a buzz is a technique called therapeutic plasma exchange, a procedure ...

World Hemophilia Day spotlights the rare blood disorder that prevents the blood from clotting and can be dangerous when left ...